Sector | Chemicals | Compare with Sector peers |
Industry | Chemicals | Compare with Industry peers |
Website | http://www.neogenchem.com | |
Market Cap | 3,967.80 Cr. | |
Enterprise Value(EV) | 4,424.09 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 12.52 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 120.09 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 47.25 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 284.82 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 5.28 | Calculated using Price: 1,504.00 |
Dividend Yield | 0.20 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.64 Cr. | 26,381,674 Shares |
FaceValue | 10 | |
About Neogen Chemicals Ltd. | ||
Neogen Chemicals is one of India's leading manufacturers of bromine-based, and lithium-based, specialty chemicals. The company manufactures specialty organic bromine-based chemical compounds (Bromine Compounds) and other specialty organic chemical compounds as well as specialty inorganic lithium-based chemicals compounds (Lithium Compounds and together with the Bromine Compounds the Products). In addition to manufacturing its standard products, the company also undertakes custom synthesis and contract manufacturing. In custom synthesis the product is developed and customized primarily for a specific customer, but process know-how and technical specifications are developed in-house by it. |
1 Day |
|
-3.23% |
1 Week |
|
+10.25% |
1 Month |
|
+20.25% |
3 Month |
|
+7.30% |
6 Month |
|
-4.08% |
1 Year |
|
-6.77% |
2 Year |
|
-3.92% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 23.61 | 20.3 | 22 | 23.78 | 34.73 | 25.31 | 18.47 | 14.34 | 10.84 | |
Return on Capital Employed (%) | 27.42 | 26.11 | 23.01 | 22.85 | 25.52 | 21.93 | 16.75 | 14.33 | 13.25 | |
Return on Assets (%) | 7.72 | 6.94 | 6.57 | 6.6 | 9.81 | 9.53 | 7.4 | 6.91 | 5.39 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 23 | 28 | 42 | 50 | 70 | 156 | 183 | 439 | 483 | 497 | |
Non Curr. Liab. | 7 | 7 | 44 | 46 | 60 | 49 | 131 | 142 | 162 | 180 | |
Curr. Liab. | 38 | 46 | 67 | 84 | 117 | 150 | 178 | 218 | 410 | 525 | |
Minority Int. | |||||||||||
Equity & Liab. | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,202 | |
Non Curr. Assets | 16 | 20 | 63 | 74 | 87 | 124 | 252 | 307 | 398 | 480 | |
Curr. Assets | 53 | 61 | 90 | 107 | 160 | 231 | 240 | 492 | 656 | 722 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,202 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 84 | 100 | 110 | 161 | 239 | 306 | 336 | 487 | 686 | 695 | |
Other Income | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 4 | 7 | |
Total Income | 85 | 100 | 110 | 162 | 240 | 306 | 337 | 488 | 691 | 702 | |
Total Expenditure | -71 | -86 | -90 | -132 | -196 | -248 | -272 | -401 | -575 | -588 | |
PBIDT | 14 | 14 | 20 | 30 | 44 | 58 | 65 | 88 | 116 | 114 | |
Interest | -5 | -5 | -8 | -10 | -12 | -12 | -14 | -19 | -29 | -42 | |
Depreciation | -1 | -1 | -1 | -2 | -3 | -5 | -7 | -12 | -16 | -21 | |
Taxation | -3 | -3 | -4 | -6 | -8 | -12 | -13 | -12 | -21 | -18 | |
Exceptional Items | |||||||||||
PAT | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 50 | 33 | |
Minority Interest | |||||||||||
Share Associate | 0 | 0 | |||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 50 | 33 | |
Adjusted EPS | 3 | 3 | 4 | 5 | 10 | 12 | 13 | 18 | 20 | 13 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 3 | 9 | 9 | 0 | 12 | -4 | -35 | 84 | 1 | -30 | |
Cash Fr. Inv. | -1 | -2 | -4 | -33 | -13 | -20 | -29 | -135 | -146 | -94 | |
Cash Fr. Finan. | -2 | -6 | -4 | 33 | 0 | 24 | 63 | 51 | 188 | 100 | |
Net Change | 0 | 1 | 0 | 1 | -1 | 0 | -1 | 0 | 44 | -25 | |
Cash & Cash Eqvt | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 45 | 21 |
Fri, 26 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Neogen Chemicals Limited has informed the Exchange about Schedule of meet |
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations Haridas Thakarshi Kanani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
Wed, 24 Apr 2024
Board Meeting Intimation NEOGEN CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-Apr-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
Fri, 26 Apr 2024 |
High Increase in 1 Month |
RSI Bearish |
William %R Bearish |
CCI Overbought Zone |
MFI Above 80 |